par de Azambuja, Evandro 
;Zardavas, Dimitros ;Lemort, Marc ;Rossari, José ;Moulin, C;Buttice, A;D'Hondt, Veronique ;Lebrun, Fabienne;Lalami, Yassine ;Cardoso, Fatima ;Sotiriou, Christos ;Gil, Thierry ;Devriendt, Daniel ;Paesmans, M.;Piccart-Gebhart, Martine ;Awada, Ahmad
Référence Annals of oncology, 24, 12, page (2985-2989)
Publication Publié, 2013-12
;Zardavas, Dimitros ;Lemort, Marc ;Rossari, José ;Moulin, C;Buttice, A;D'Hondt, Veronique ;Lebrun, Fabienne;Lalami, Yassine ;Cardoso, Fatima ;Sotiriou, Christos ;Gil, Thierry ;Devriendt, Daniel ;Paesmans, M.;Piccart-Gebhart, Martine ;Awada, Ahmad Référence Annals of oncology, 24, 12, page (2985-2989)
Publication Publié, 2013-12
Article révisé par les pairs
| Titre: |
|
| Auteur: | de Azambuja, Evandro; Zardavas, Dimitros; Lemort, Marc; Rossari, José; Moulin, C; Buttice, A; D'Hondt, Veronique; Lebrun, Fabienne; Lalami, Yassine; Cardoso, Fatima; Sotiriou, Christos; Gil, Thierry; Devriendt, Daniel; Paesmans, M.; Piccart-Gebhart, Martine; Awada, Ahmad |
| Informations sur la publication: | Annals of oncology, 24, 12, page (2985-2989) |
| Statut de publication: | Publié, 2013-12 |
| Sujet CREF: | Cancérologie |
| Médecine pathologie humaine | |
| MeSH keywords: | Adult |
| Aged | |
| Antineoplastic Combined Chemotherapy Protocols -- pharmacology -- therapeutic use | |
| Brain Neoplasms -- drug therapy -- metabolism -- mortality -- secondary | |
| Breast Neoplasms -- drug therapy -- metabolism -- mortality -- pathology | |
| Dacarbazine -- administration & dosage -- analogs & derivatives | |
| Disease-Free Survival | |
| Female | |
| Humans | |
| Maximum Tolerated Dose | |
| Middle Aged | |
| Quinazolines -- administration & dosage | |
| Receptor, ErbB-2 -- metabolism | |
| Treatment Outcome | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0923-7534 |
| info:doi/10.1093/annonc/mdt359 | |
| info:pii/mdt359 | |
| info:scp/84888804829 | |
| info:pmid/24013582 |
